fcgamma1-fel d1 fusion protein
Allergenexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01292070)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, desensitized
Immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fcgamma1-fel d1 fusion protein
- fcγ1-fel d1 fusion protein
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01292070 | Early Phase 1 (Phase 1) | Mar 1, 2011 | Immune Tolerance Network, National Institute of Allergy and Infectious Diseases (NIAID), Tunitas Therapeutics, Inc., University of California, Los Angeles |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immune Tolerance Network | Academic/Hospital | 1 | 0 | 1 | 2011 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2011 |
| Tunitas Therapeutics, Inc. | For profit | 1 | 0 | 1 | 2011 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2011 |
4 organizations
Page 1 / 1